Keywords: تومورهای جامد; Cytokines; IL-6; Lymphomas; Solid tumors; TNF-α; Undernutrition;
مقالات ISI تومورهای جامد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تومورهای جامد; Central venous catheter; Hand strength; Solid tumors; Venous thrombosis;
Keywords: تومورهای جامد; Anti-tumorigenic; Clinical outcome; Glucocorticoids; Pre-clinical; Pro-tumorigenic; Solid tumors;
Keywords: تومورهای جامد; 20-MC; 20-Methylcholanthrene; 3-MC; 3-Methylcholanthrene; ALDH; aldehyde dehydrogenase A1; AsA; ascorbate; APx; ascosbate peroxidase; As2O3; arsenic trioxide; BSO; L-buthionine-(S,R)-sulfoximine; CNS; Central Nervous System; DMBA; 7,12-Dimethylbenz[a]anth
Keywords: تومورهای جامد; Cancer; Solid tumors; Blood tumors; Brain tumors; Neurooncology; Transdifferentiation; Chemotherapy; Differentiation based therapies; Naturally occurring compounds; Aloe emodin; Isoxanthohumol;
Keywords: تومورهای جامد; Nitric oxide; prostate cancer; bladder cancer; nitric oxide donors; solid tumors;
Keywords: تومورهای جامد; Controlling nutritional status scores; Solid tumors; Clinical outcomes;
Keywords: تومورهای جامد; Lactic acidosis; Solid tumors; Chemotherapy; Liver; Tumor burden;
Keywords: تومورهای جامد; Multiphoton microscopy; Solid tumors; Pediatric; Histopathology; Frozen section;
Keywords: تومورهای جامد; Hematological malignancies; Order of treatment; Solid tumors; Synchronous multiple primary malignant tumors; Treatment discontinuation;
Keywords: تومورهای جامد; Targeted therapy; Solid Tumors; Tyrosine kinase inhibitors; Monoclonal antibodies;
Keywords: تومورهای جامد; Topoisomerase I; Topoisomerase IIα; HER2; Genomic profiling; Solid tumors;
Keywords: تومورهای جامد; Epigenetics; Cancer; Solid tumors; Epigenetic therapy; Chemosensitization;
Keywords: تومورهای جامد; Human mesenchymal stromal cells; Solid tumors; Metastasis; Antitumor treatment; Curative effect; Enzyme/prodrug therapy;
Keywords: تومورهای جامد; Caveolae; Endothelial cells; Drug delivery; Solid Tumors; Tumor targeting; Tumor vasculature;
Keywords: تومورهای جامد; apoptosis; autophagy; bortezomib; proteasome inhibitors; solid tumors
Keywords: تومورهای جامد; CTCs; DTCs; Cell lines; Solid tumors; Biomarkers; Liquid biopsy;
Keywords: تومورهای جامد; Solid tumors; Nanoparticles; Perfusion; Extravasation; Dynamic drug delivery
Keywords: تومورهای جامد; Biomarker; Client proteins; HER2; HSP90; Solid tumors;
Keywords: تومورهای جامد; Anthracyclines; Solid tumors; Drug delivery systems; Transferrin;
Keywords: تومورهای جامد; Cancer; Solid tumors; Metastasis; Inhibitors; Drug development;
Keywords: تومورهای جامد; Platelets; Platelet secretion; Solid tumors; Microenvironment; Leukemia;
Keywords: تومورهای جامد; Thrombosis; Solid tumors; Standard treatment; Survival;
Keywords: تومورهای جامد; Adenocarcinoma  of the lung; Non-small cell lung cancer (NSCLC); Solid tumors; Squamous cell lung cancer; Tumor lysis syndrome (TLS);
Keywords: تومورهای جامد; Pneumothorax; Antiangiogenic; Solid tumors; Cavitary pulmonary lesions
Keywords: تومورهای جامد; Pediatric cancer; Solid tumors; Health disparities; Survival
Keywords: تومورهای جامد; Lymphocyte-to-monocyte ratio (LMR); Meta-analysis; Prognostic factor; Solid tumors; Systematic review;
Keywords: تومورهای جامد; Solid tumors; Plasma fibrinogen; Prognosis; Biomarker; Meta-analysis;
Keywords: تومورهای جامد; cellules tumorales circulantes; tumeurs solides; pronostic; biopsie liquide; circulating tumor cells; solid tumors; prognosis; liquid biopsy;
Keywords: تومورهای جامد; Hematopoietic cell transplantation; Reduced-intensity conditioning; Nonmyeloablative conditioning; Second cancers; Solid tumors
Keywords: تومورهای جامد; cancer; epidemiology; infants; leukemia; solid tumors
Keywords: تومورهای جامد; Aspergillus; Invasive pulmonary aspergillosis; Subacute invasive aspergillosis; Chronic pulmonary aspergillosis; Solid tumors; Solid cancer; Lung cancer; Lung metastasis; BAL; bronchoalveolar lavage; COPD; chronic obstructive pulmonary disease; CPA; chron
Keywords: تومورهای جامد; Hypoxia-inducible factor; HIF-1α; Quantitative ELISA; Pharmacodynamics; Solid tumors
Keywords: تومورهای جامد; Immunotherapy; Solid tumors; Adoptive cell transfer therapy
Keywords: تومورهای جامد; Solid tumors; Cancer related fatigue; Inflammation; Malnutrition; Glutamine
Prognostic value of PEG10 in Asian solid tumors: A meta-analysis
Keywords: تومورهای جامد; PEG10; Solid tumors; Prognosis; Meta-analysis;
Prognostic value of DcR3 in solid tumors: A meta-analysis
Keywords: تومورهای جامد; Decoy receptor 3; Solid tumors; Prognosis; Meta-analysis;
CAR-T cells and combination therapies: What's next in the immunotherapy revolution?
Keywords: تومورهای جامد; CAR; chimeric antigen receptor; iRs; inhibitory receptors; mAbs; monoclonal antibodies; SMIs; Small molecule inhibitors; KIs; kinase inhibitors; CAR-T cells; Solid tumors; Targeted-therapies; Combination therapies; Synthetic biology; Systems biology;
Antibody-drug conjugates (ADCs): Potent biopharmaceuticals to target solid and hematological cancers- an overview
Keywords: تومورهای جامد; Antibody-drug conjugates; Monoclonal antibodies; Anticancer; Drug resistance; Solid tumors; Hematological tumors; ADC; Antibody-Drug Conjugate; ALCL; Anaplastic Large Cell Lymphoma; ALL; Acute Lymphoblastic Leukemia; AML; Acute Myeloid Leukemia; BCMA; B C
ARLTS1, potential candidate gene in familial aggregation of hematological malignancies
Keywords: تومورهای جامد; ARLTS1; Familial hematological malignancy; Solid tumors; ARLTS1; Hémopathies malignes familiales; Tumeurs solides;
Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: From laboratory to patients
Keywords: تومورهای جامد; Solid tumors; Phosphoinositide 3-kinase; Inhibitors; Lessons; Laboratory; Clinical trial;
Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: Clinical data to date, current limitations and perspectives
Keywords: تومورهای جامد; Review; Chimeric antigen receptor therapy; Hematological malignancies; Solid tumors; Adoptive T-cell therapy;
Bruton's tyrosine kinase (BTK) as a promising target in solid tumors
Keywords: تومورهای جامد; Ibrutinib; Bruton tirosine kinase; Solid tumors; Checkpoint inhibitors; Tumor microenvironment; TEC kinases;
Nano-sized drug carriers: Extravasation, intratumoral distribution, and their modeling
Keywords: تومورهای جامد; Nanoparticle delivery; Solid tumors; Extravasation; Intratumoral distribution; Tumor models; Predictive power;
CD44: More than a mere stem cell marker
Keywords: تومورهای جامد; CD44; Hyaluronan; Osteopontin; Cancer stem cells; Solid tumors; leukemia;
MassARRAY determination of somatic oncogenic mutations in solid tumors: Moving forward to personalized medicine
Keywords: تومورهای جامد; MassARRAY technology; OncoCarta panel v1.0; Somatic mutation profile; Solid tumors
Chimiothérapie à hautes doses comme stratégie pour contourner la résistance aux médicaments dans les tumeurs solides
Keywords: تومورهای جامد; Hautes doses de chimiothérapie; Tumeurs germinales; Autogreffe de cellules-souches; Tumeurs solides; Cancer du sein; Cancer de l'ovaire; High-dose chemotherapy; Germ cell tumors; Autologous stem cell transplant; Solid tumors; Breast cancer; Ovarian can
Methylation status of homeobox genes in common human cancers
Keywords: تومورهای جامد; DNA methylation; Homeobox genes; Epigenetic; Solid tumors;
CDH1/E-cadherin and solid tumors. An updated gene-disease association analysis using bioinformatics tools
Keywords: تومورهای جامد; CDH1; Epithelial Cadherin; Solid tumors; Bioinformatics; Somatic mutations
A rapid and accurate closed-tube Methylation-Sensitive High Resolution Melting Analysis assay for the semi-quantitative determination of SOX17 promoter methylation in clinical samples
Keywords: تومورهای جامد; cfDNA; cell free DNA; CTCs; Circulating Tumor Cells; FFPEs; formalin fixed paraffin embedded; MS-HRMA; Methylation-Sensitive High Resolution Melting Analysis; MSP; methylation Specific PCR; SB; sodium bisulfite; SOX; Sry-related high mobility group box.;